人血清白蛋白的基于血红素的催化特性。

Heme-based catalytic properties of human serum albumin.

作者信息

Ascenzi P, di Masi A, Fanali G, Fasano M

机构信息

Interdepartmental Laboratory for Electron Microscopy, Roma Tre University , 00146 Roma, Italy.

Interdepartmental Laboratory for Electron Microscopy, Roma Tre University, 00146 Roma, Italy; Department of Sciences, Roma Tre University, 00146 Roma, Italy.

出版信息

Cell Death Discov. 2015 Sep 7;1:15025. doi: 10.1038/cddiscovery.2015.25. eCollection 2015.

Abstract

Human serum albumin (HSA): (i) controls the plasma oncotic pressure, (ii) modulates fluid distribution between the body compartments, (iii) represents the depot and carrier of endogenous and exogenous compounds, (iv) increases the apparent solubility and lifetime of hydrophobic compounds, (v) affects pharmacokinetics of many drugs, (vi) inactivates toxic compounds, (vii) induces chemical modifications of some ligands, (viii) displays antioxidant properties, and (ix) shows enzymatic properties. Under physiological and pathological conditions, HSA has a pivotal role in heme scavenging transferring the metal-macrocycle from high- and low-density lipoproteins to hemopexin, thus acquiring globin-like reactivity. Here, the heme-based catalytic properties of HSA are reviewed and the structural bases of drug-dependent allosteric regulation are highlighted.

摘要

人血清白蛋白(HSA):(i)控制血浆胶体渗透压,(ii)调节身体各腔室之间的液体分布,(iii)是内源性和外源性化合物的储存库和载体,(iv)增加疏水化合物的表观溶解度和寿命,(v)影响许多药物的药代动力学,(vi)使有毒化合物失活,(vii)诱导一些配体的化学修饰,(viii)具有抗氧化特性,以及(ix)具有酶促特性。在生理和病理条件下,HSA在血红素清除中起关键作用,将金属大环从高密度和低密度脂蛋白转移至血红素结合蛋白,从而获得类珠蛋白反应性。在此,对HSA基于血红素的催化特性进行综述,并突出药物依赖性变构调节的结构基础。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bbc/4991842/764d9f4efb27/cddiscovery201525-f1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索